1. Home
  2. CYTH vs ONMD Comparison

CYTH vs ONMD Comparison

Compare CYTH & ONMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTH
  • ONMD
  • Stock Information
  • Founded
  • CYTH 1990
  • ONMD 2006
  • Country
  • CYTH United States
  • ONMD United States
  • Employees
  • CYTH N/A
  • ONMD N/A
  • Industry
  • CYTH Biotechnology: Pharmaceutical Preparations
  • ONMD
  • Sector
  • CYTH Health Care
  • ONMD
  • Exchange
  • CYTH Nasdaq
  • ONMD Nasdaq
  • Market Cap
  • CYTH 20.4M
  • ONMD 23.9M
  • IPO Year
  • CYTH N/A
  • ONMD N/A
  • Fundamental
  • Price
  • CYTH $0.69
  • ONMD $0.89
  • Analyst Decision
  • CYTH Buy
  • ONMD
  • Analyst Count
  • CYTH 3
  • ONMD 0
  • Target Price
  • CYTH $0.95
  • ONMD N/A
  • AVG Volume (30 Days)
  • CYTH 21.2K
  • ONMD 498.5K
  • Earning Date
  • CYTH 11-14-2024
  • ONMD 12-03-2024
  • Dividend Yield
  • CYTH N/A
  • ONMD N/A
  • EPS Growth
  • CYTH N/A
  • ONMD N/A
  • EPS
  • CYTH N/A
  • ONMD N/A
  • Revenue
  • CYTH $870,725.00
  • ONMD $1,021,651.00
  • Revenue This Year
  • CYTH N/A
  • ONMD N/A
  • Revenue Next Year
  • CYTH $24.49
  • ONMD N/A
  • P/E Ratio
  • CYTH N/A
  • ONMD N/A
  • Revenue Growth
  • CYTH N/A
  • ONMD N/A
  • 52 Week Low
  • CYTH $0.59
  • ONMD $0.42
  • 52 Week High
  • CYTH $2.12
  • ONMD $4.43
  • Technical
  • Relative Strength Index (RSI)
  • CYTH 47.10
  • ONMD 50.76
  • Support Level
  • CYTH $0.61
  • ONMD $0.76
  • Resistance Level
  • CYTH $0.77
  • ONMD $0.87
  • Average True Range (ATR)
  • CYTH 0.05
  • ONMD 0.12
  • MACD
  • CYTH -0.00
  • ONMD -0.00
  • Stochastic Oscillator
  • CYTH 55.63
  • ONMD 49.82

About CYTH Cyclo Therapeutics Inc.

Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company is engaged in developing cyclodextrin-based products for treating neurodegenerative diseases, particularly Niemann-Pick Type C disease (NPC). The company's lead drug candidate, Trappsol Cyclo, has undergone clinical trials for NPC treatment. Operating in one segment, the company focuses on developing and commercializing cyclodextrin-based treatments for rare diseases. Revenue primarily comes from selling cyclodextrins and related products to pharmaceutical and nutritional industries, with Trappsol HPB and Trappsol Fine Chemical being significant contributors.

About ONMD OneMedNet Corp

OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a global provider of clinical imaging innovation and curator of regulatory-grade Imaging Real-World Data or iRWDTM. OneMedNet's innovative solutions connect healthcare providers and patients satisfying a crucial need within the Life Sciences field offering direct access to clinical images and the associated contextual patient record.

Share on Social Networks: